BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -5.83% | -10.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.83% | -10.35% | |||
| Cost of Revenue | -49.58% | -2.41% | |||
| Gross Profit | 3,865.18% | -89.06% | |||
| SG&A Expenses | 393.26% | -4.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.39% | -2.68% | |||
| Operating Income | -85.47% | -202.41% | |||
| Income Before Tax | -106.66% | -447.76% | |||
| Income Tax Expenses | 409.91% | -446.93% | |||
| Earnings from Continuing Operations | -302.64% | -448.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -302.64% | -448.07% | |||
| EBIT | -85.47% | -202.41% | |||
| EBITDA | -155.21% | -541.67% | |||
| EPS Basic | -302.61% | -448.14% | |||
| Normalized Basic EPS | -106.64% | -447.89% | |||
| EPS Diluted | -302.90% | -448.14% | |||
| Normalized Diluted EPS | -106.64% | -447.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||